Tag: GLP-1 RAs
What periop nurses should preoperatively know about GLP-1, oral GLP-1 drugs
With the explosion of GLP-1–based therapies for type 2 diabetes and weight loss, perioperative nursing teams, especially in the preoperative and postanesthesia care areas, need to be fluent in recognizing these medications. Some patients may arrive on these agents—or even novel oral GLP-1s—and the physiologic effects, especially delayed gastric emptying,…
GLP-1 drugs show promise for preoperative weight loss
Editor's Note Glucagon-like peptide-1 (GLP-1) receptor agonists may offer orthopedic patients with obesity and type 2 diabetes a powerful tool for preoperative weight loss and potential disease modification, according to a July 10 review article in The Journal of Bone and Joint Surgery. However, the agents carry perioperative risks that…
Free Daily News
- Governors form alliance to fill federal public health gaps amid cuts, shutdown
- UnitedHealthcare anesthesia cuts spark backlash over patient access risks
- Your playbook for OR wins is in Anaheim
- UCSF surgeons spotlight innovation, perioperative research at national surgical conference
- FDA recalls affect surgical staplers, OR procedure kits, ultrasound systems used in hospitals
- C-sections linked to longer recovery, higher pain, sleep problems for new mothers
- AI model grades nursing procedures with near-human precision
- Study: Hospitals can safely cut low-value preop tests before routine surgeries
- New studies highlight opportunities to improve pediatric anesthesia safety, comfort
- Social and behavioral factors emerging as key predictors of recovery quality after surgery
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement